Community Research and Development Information Service - CORDIS

Horizon 2020 project information and now also report summaries are available on CORDIS. All H2020 projects can be downloaded from the EU Open Data Portal .

My refinements


Download results of this page


Refine by:

Subject

Life Sciences (23)

Programme

FP7
All
FP7-HEALTH (23)

Country

Austria (1)
Belgium (5)
Denmark (3)
Finland (3)
France (13)
Germany (15)
Greece (1)
Hungary (1)
Iceland (1)
Ireland (1)
Israel (1)
Italy (5)
Latvia (1)
Netherlands (12)
Norway (1)
Portugal (1)
Spain (5)
Sweden (9)
Switzerland (4)
United Kingdom (16)

Language

English (23)

Advanced search

Results 1 - 10 of 23
Order by: Results/page:
12 3 > 
High Efficient, Single-Use-Bioreactor simulating mammalian tissue conditions for expression and proliferation
ID: 601700
Start date: 2013-05-01, End date: 2016-04-30
A unique combination of earlier EU funded projects allow four research SME´s to create a combined most visionary and innovative product for improved health. There is a strategic decision from pharmaceutical companies and hospitals for: 1. continues expressing of biologicals t...
Programme: FP7-HEALTH
Record Number: 108560
Last updated on: 2017-05-08
Evaluation of phage therapy for the treatment of Escherichia coli and Pseudomonas aeruginosa burn wound infections (Phase I-II clinical trial)
ID: 601857
Start date: 2013-06-01, End date: 2017-02-28
Sepsis is the major problem of large burn patients and a predominant cause of death. The burn wound pathology, combined to a global intensive use of antibiotics (ATB), put patients at high risk of suffering from multidrug resistant (MDR) infections, notably carried out by the...
Programme: FP7-HEALTH
Record Number: 108695
Last updated on: 2017-04-24
Combined Multi-marker Screening and Randomised Patient Treatment with Aspirin for Evidence-based Pre-eclampsia Prevention
ID: 601852
Start date: 2013-05-01, End date: 2016-10-31
"Project ASPRE is a commercially led development project that aims to boost translation of the results of PREGENESYS (FP6 EU #37244) into effective applications for prenatal care. PREGENESYS has identified several biomarkers for early (11-13 weeks’ gestation) and effective id...
Programme: FP7-HEALTH
Record Number: 108784
Last updated on: 2017-03-22
Targeting the HIV-1 Nucleocapsid Protein to fight Antiretroviral Drug Resistance
ID: 601969
Start date: 2013-09-01, End date: 2016-08-31
AIDS is one of the most serious pandemic diseases of the modern era. Although current therapies based on targeting key processes of the HIV replication cycle are potent and selective, several clinical failures are recorded due to the emergence of drug resistance. Hence, there...
Programme: FP7-HEALTH
Record Number: 108562
Last updated on: 2016-12-26
Translation of the direct-on-blood PCR-NALFIA system into an innovative near point-of-care diagnostic for malaria
ID: 601714
Start date: 2013-09-01, End date: 2017-02-28
Accurate diagnosis of malaria is essential to timely install proper treatment. Current diagnostic methods for malaria have limitations, such as detection limit and problems with antigen persistence after successful treatment (rapid diagnostic tests) or may require technical e...
Programme: FP7-HEALTH
Record Number: 108624
Last updated on: 2016-12-19
bioREACtor for stem cell tHerapy
ID: 601869
Start date: 2013-07-01, End date: 2016-06-30
The REACH-project is a direct result of the FP7 StemExpand project, which aimed at the expansion and engraftment of hematopoietic and mesenchymal stem cells (MSC) for clinical use. The results of these research activities show that a novel, closed and controlled bioreactor ca...
Programme: FP7-HEALTH
Record Number: 108812
Last updated on: 2016-11-07
Cancer Responsiveness Monitoring based on Resistance mutations in CTCs
ID: 601760
Start date: 2013-09-01, End date: 2016-08-31
Today's treatment of metastatic breast cancer is guided by characterisation of the primary tumour while 90% of deaths due to breast cancer occur as a consequence of metastases. Given important differences in molecular characteristics between metastases and primary tumour tiss...
Programme: FP7-HEALTH
Record Number: 109824
Last updated on: 2016-09-19
New AntiBacterials with Inhibitory activity on Aminoacyl-tRNA Synthetases
ID: 601725
Start date: 2013-06-01, End date: 2016-05-31
The NABARSI consortium will develop a cutting-edge drug discovery project to increase the antibacterial pipeline. The main goal of NABARSI is to find new chemical entities (NCEs) with antibacterial efficacy in animal models of multi-drug resistant (MDR) bacterial infection an...
Programme: FP7-HEALTH
Record Number: 108677
Last updated on: 2016-09-05
Donor T Cells for Immune Control
[PROJECT] T-CONTROL - Donor T Cells for Immune Control
ID: 601722
Start date: 2013-05-01, End date: 2017-01-31
Patients with high-risk hematological tumors can be cured by allogeneic hematopoietic stem cell transplantation (HSCT). However, the main causes of failure of HSCT are infections, tumor relapse and over-shooting immune responses of the donor T cells to healthy cells and tissu...
Programme: FP7-HEALTH
Record Number: 108561
Last updated on: 2016-08-29
First in Man Novel Anticancer Therapeutic based on Dependence Receptors Concept
ID: 601716
Start date: 2013-09-01, End date: 2016-08-31
It is usually assumed that transmembrane receptors are inactive unless bound by their respective ligand. Against this dogma, the CLB proposed that some receptors may also be active in the absence of ligand and in this case trigger cell death. These receptors were called depen...
Programme: FP7-HEALTH
Record Number: 108733
Last updated on: 2016-08-29
12 3 > 
List retrieved on: 2017-07-22
Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top